Controlling alpha for mixed effects models for repeated measures

被引:1
|
作者
Ye, Zhishen [1 ]
Bekele, B. Nebiyou [1 ]
机构
[1] Gilead Sci Inc, Dept Biostat, 353 Lakeside Dr, Foster City, CA 94404 USA
关键词
Alpha control; clinical trials; group sequential testing; interim analysis; MMRM; CLINICAL-TRIALS;
D O I
10.1080/10543406.2018.1439052
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Mixed Effects Models for Repeated Measures (MMRM) is often used in clinical trials with longitudinal data. However, there has not been an in-depth examination available on how investigators can implement interim analysis while also controlling the overall alpha for clinical trials under an MMRM analysis framework. Statistical independence among measurements, which is often assumed in group sequential testing (GST), is not valid under an MMRM framework due to the correlations induced by longitudinal within-subject measurements. Therefore, methods associated with GST derived under independence need to be adjusted accordingly. While these correlations can be estimated from the study data, regulatory agencies may not accept results based on these estimated correlations since there is no guarantee that the overall alpha is strongly controlled. In this article, we propose a new AC-Hybrid-approach for controlling the overall alpha. The AC-Hybrid-approach has two key attributes. First, we apply the MMRM analysis framework on all available data at every analysis timepoint. Second, we use complete-case information fractions to derive the group sequential stopping boundaries. We prove that the overall alpha is controlled regardless of the correlations among within-subject measurements. We also show the impact of this approach on the alpha and the power through examples.
引用
收藏
页码:1055 / 1077
页数:23
相关论文
共 50 条
  • [21] Methods for assessing and controlling placebo effects
    Kessels, Rob
    Mozer, Reagan
    Bloemers, Jos
    STATISTICAL METHODS IN MEDICAL RESEARCH, 2019, 28 (04) : 1141 - 1156
  • [22] SAMPLE-SIZE CALCULATIONS FOR 2-GROUP REPEATED-MEASURES EXPERIMENTS
    ROCHON, J
    BIOMETRICS, 1991, 47 (04) : 1383 - 1398
  • [23] Testing Mean Differences among Groups: Multivariate and Repeated Measures Analysis with Minimal Assumptions
    Bathke, Arne C.
    Friedrich, Sarah
    Pauly, Markus
    Konietschke, Frank
    Staffen, Wolfgang
    Strobl, Nicolas
    Hoeller, Yvonne
    MULTIVARIATE BEHAVIORAL RESEARCH, 2018, 53 (03) : 348 - 359
  • [24] Measuring the individual benefit of a medical or behavioral treatment using generalized linear mixed-effects models
    Diaz, Francisco J.
    STATISTICS IN MEDICINE, 2016, 35 (23) : 4077 - 4092
  • [25] More powerful two-sample tests for differences in repeated measures of adverse effects in psychiatric trials when only some patients may be at risk
    McMahon, RP
    Arndt, S
    Conley, RR
    STATISTICS IN MEDICINE, 2005, 24 (01) : 11 - 21
  • [26] Repeated Measures Analyses in Clinical Trials with Titration Visits
    Phillip Dinh
    Peiling Yang
    Drug information journal : DIJ / Drug Information Association, 2009, 43 (5): : 595 - 602
  • [27] Repeated Measures Analyses in Clinical Trials With Titration Visits
    Dinh, Phillip
    Yang, Peiling
    DRUG INFORMATION JOURNAL, 2009, 43 (05): : 595 - 602
  • [29] Rapid Sample Size Calculations for a Defined Likelihood Ratio Test-Based Power in Mixed-Effects Models
    Vong, Camille
    Bergstrand, Martin
    Nyberg, Joakim
    Karlsson, Mats O.
    AAPS JOURNAL, 2012, 14 (02): : 176 - 186
  • [30] On summary measure analysis of linear trend repeated measures data: performance comparison with two competing methods
    Vossoughi, Mehrdad
    Ayatollahi, S. M. T.
    Towhidi, Mina
    Ketabchi, Farzaneh
    BMC MEDICAL RESEARCH METHODOLOGY, 2012, 12